Advertisement
    Earlier today
    Yesterday
    In the last 7 days
    In the last month
    Novartis bets on autoimmune BiTEs through $7.8bn Abogen deal Pharmaceutical Technology11:27 2-Oct-26
    Novartis Eyes Platform Benefits In $7.2bn Abogen Alliance Scrip Pharma Intelligence08:15 2-Oct-26
    Community health takes a village: from Pulpit to Pew Novartis (Press Release)09:37 30-Sept-26
    Nevian signs Sandoz deal to widen medicine portfolio The Daily Star, Bangladesh18:35 26-Sept-26
    Roche targets Novartis on IgAN market after Phase III win Clinical Trials Arena09:25 25-Sept-26
    The Day AI Made Me Rethink What Science Could Do Novartis (Press Release)09:37 24-Sept-26
    BoomRay and Novartis Pharma sign $900m deal for radioligand therapy Pharmaceutical Business Review10:45 23-Sept-26
    American Chemical Society honors Novartis researchers Novartis (Press Release)01:19 22-Sept-26
    Novartis’s Christian Diehl on scaling AI beyond the demo The McKinsey Quarterly17:11 21-Sept-26
    Novartis M&A Strategy Not So Bad As Claimed? Scrip Pharma Intelligence15:07 18-Sept-26
    view more headlines
    15 Oct 03:31

    About our Novartis news

    Latest news for Novartis, a global healthcare company based in Switzerland specialising in pharmaceuticals, including updates on company and product news.


    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.